Chapter 10 Upstream Processing - Biomanufacturing
upstream processing is the growth of either bacterial or cell culture-based protein products, referred to as microbial fermentation or mammalian cell culture respectively. These disease-fighting proteins are collectively called Active Pharmaceutical Ingredients, or APIs
Download Chapter 10 Upstream Processing - Biomanufacturing
Information
Domain:
Source:
Link to this page:
Documents from same domain
Title: Column Chromatography of Green …
biomanufacturing.orgTitle: Column Chromatography of Green Fluorescent Protein ... 4.1 Instructions from Biotechnology Explorer Green Fluorescent Protein ... (Bio-Rad catalog number 166 ...
Overview Development and Manufacturing of …
biomanufacturing.org2 Development and Manufacturing of Parenteral Drug Products Unit Overview Development and Manufacturing of Injectable (Parenteral) Drug Products From discovering the active ingredient to manufacturing the finished product, the production of
Chapter 11 Downstream Processing - Biomanufacturing
biomanufacturing.orgTable 11-1: Commonly employed downstream processing methods (adapted from Kemp and O’Neil 2003) Processing Method Attributes Benefits Limitations Clarification: (often considered part of the upstream processing train) Sedimentation- based Clarification continuous centrifugation capable of handling very large harvest volumes open process-
Chapter 14 Sterile Filtration, Filling, and Lyophilization ...
biomanufacturing.orgcontainers (pharmaceutical container/closure). This operation exposes the sterile product to the environment, equipment, and manipulative technique of the operators until it can be sealed in the dose container; therefore, this operation is performed with a minimum exposure
Chapter 13 Formulation Development of Parenteral Products
biomanufacturing.org4 Chapter 13 – Formulation of Parenteral Products Introduction to Parenteral Products Basic theory Parenteral (para enteron—beside the intestine) administration is the introduction into the body of nutrition, medications, or other substances other than by the alimentary canal.
Introduction to TFF - Biomanufacturing
biomanufacturing.orgtests to establish a baseline for the device performance. 7. Equilibrate system with the sample buffer (it helps remove air from the system, adjust system temperature and prevent possible precipitation or denaturation of biomolecules resulting from contact with flushing solution). 8. Process the Product (concentration and /or diafiltration, or
Chapter 15 Inspection, Labeling, and Packaging
biomanufacturing.orginspection without impacting overall batch quality. The American National Standards Institute/American Society for Quality Control (ANSI/ASQC) Z1.4-2008, Sampling Procedures and Tables for Inspection by Attributes is the primary reference used for setting AQL levels. Table 15-1. Sample AQL table based on ANSI/ASQC, Z1.4-2008 Batch Size Sample Size
Chapter 10 Upstream Processing - Biomanufacturing
biomanufacturing.orguse of airflow booths and following cleaning protocol explain the in-process controls for assessing media components illustrate the major types of bioreactors and associated instruments used for upstream biomanufacturing evaluate situations in order to make appropriate aseptic decisions
Chapter 11 Downstream Processing - Biomanufacturing
biomanufacturing.org424 Chapter 11 - Downstream Processing Objectives This chapter provides an overview of downstream processing. After completing this chapter, students will be able to: Describe the general elements of the downstream purification process for a typical monoclonal antibody-based therapeutic, starting with the bioreactor harvest pool and
Chapter 9 Quality Control Biochemistry
biomanufacturing.org344 Chapter 9 - Quality Control: Biochemistry and reproducibility (inter-laboratory variability). Chapter 4 Metrology covers precision and the related term accuracy Purity assay: a quantitative analytical procedure used to determine the purity of the active product ingredient Purity method: a qualitative analytical procedure used to determine the purity of the active
Related documents
Annex 3 WHO good manufacturing practices for ...
www.who.intSterile solutions intended for parenteral application with a volume of 100 ml or more in one container of the fi nished dosage form. manufacture All operations of purchase of materials and products, production, quality control (QC), release, storage and distribution of pharmaceutical products, and the related controls. manufacturer
Q 7 Good Manufacturing Practice for Active Pharmaceutical ...
www.ema.europa.euapplies to the manufacture of sterile APIs only up to the point immediately prior to the APIs being rendered sterile. The sterilization and aseptic processing of sterile APIs are not covered by this guidance, but should be performed in accordance with GMP guidelines for drug (medicinal) products as defined by local authorities.
SCHEDULE M
ipapharma.orgpharmaceutical products like penicillin or biological preparations with live micro-organisms. Separate dedicated facilities shall be provided for the manufacture of contamination causing and potent products such as Beta-Lactum, sex hormones and cytotoxic substances. 3.3. Working and in-process space shall be adequate to permit orderly and